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Abstract
Background:  Screening programmes should be organized to translate theoretical efficacy into
effectiveness. An evidence-based organizational model of colorectal cancer screening (CRCS) should
assure feasibility and high compliance.
Methods:  A multidisciplinary Working Group (WG), reviewed literature and guidelines to define
evidence-based recommendations. The WG identified the need for further local studies: physicians' CRCS
attitudes, the effect of test type and provider on compliance, and individual reasons for non-compliance.
A survey of digestive endoscopy services was conducted. A feasibility study on a target population of
300.000 has begun.
Results: Based on the results of population trials and on literature review the screening strategy adopted
was Faecal Occult Blood Test (FOBT) every two years for 50–74 year olds and, for positives, colonoscopy.
The immunochemical test was chosen because it has 20% higher compliance than the Guaiac. GPs were
chosen as the preferred provider also for higher compliance. Since we observed that distance is the major
determinant of non-compliance, we choose GPs because they are the closest providers, both
geographically and emotionally, to the public.
The feasibility study showed several barriers: GP participation was low, there were administrative
problems to involve GPs; opportunistic testing by the GPs; difficulties in access to Gastroenterology
centres; difficulties in gathering colonoscopy results; little time given to screening activity by the
gastroenterology centre.
Conclusion: The feasibility study highlighted several limits of the model. Most of the barriers that
emerged were consequences of organisational choices not supported by evidence. The principal limit was
a lack of accountability by the participating centres.
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Background
Colorectal cancer screening (CRCS) for average-risk indi-
viduals using the faecal occult blood test (FOBT) is effec-
tive in reducing mortality from CRC and its use is
generally recommended [1-4].
The challenges of disseminating evidence-based interven-
tions are shared by stakeholders, researchers, the intended
providers, the intended consumers [5] and, of course, gov-
ernmental health agencies.
While quality-assurance monitoring is carried out to
ensure safe procedures and practice in every clinical aspect
of a screening-programme [6], planning and organisation
are the only aspects not routinely monitored, yet are the
strongest tools to assure the effectiveness of screening [7].
Well-planned interventions have been associated with sta-
tistically greater results, particularly for CRCS [8]. Unfor-
tunately, the organizational aspects of an intervention are
not usually subject to the same evidence-oriented criteria
we apply to medical technologies or clinical procedures.
The impact of CRCS is directly related to its ability to
involve the target population, to detect cancers and high-
grade adenomas, and to assure patient safety; therefore
the main aspects to address at the local level when plan-
ning and implementing a CRC screening program are the
following:
- How to obtain high compliance [8,9].
- Which Type of screening test among those available
(colonoscopy, flexosygmoidoscopy, FOBT Guaiac and the
Immunochemical) [10-12].
- Screening knowledge and attitudes of the involved Phy-
sicians (GPs and gastroenterologists). [13,14].
- The GP's role in the screening programme. [1,15,16].
- The available Endoscopy resources and the additional
workload in case of screening. [3,4].
This paper describes the research involved in planning a
colorectal cancer screening program in the Lazio region,
Italy, and reports the results of the feasibility study con-
ducted to test the organisational model.
Methods
Setting
The Lazio region has 5.3 million inhabitants and includes
the city of Rome; the CRCS target population (i.e. people
aged 50–74) is 1.5 million.
The Regional Public Health Agency (RPHA) is a technical
branch of the regional government of Lazio: it coordi-
nates, monitors and evaluates breast and cervical cancer
screening in the 12 Local Health Units. The local govern-
ment gave a mandate to the RPHA to organize CRCS, with
an experimental phase, and a feasibility study [17-22].
The Colorectal Cancer Working Group (CRCWG)
The method adopted was based on organizing a Colorec-
tal Cancer Working Group (CRCWG) made up of the
principle professional figures involved: experts in gastro-
enterology, epidemiology, screening program organizers,
general practitioners; representatives of the physicians'
unions and of the regional scientific societies of endo-
scopists and gastroenterologists. The CRCWG reviewed
the guidelines available, giving greater weight to those
from governmental bodies; it also reviewed the literature
regarding the characteristics of FOBT. They made opera-
tional recommendations based on those found in the lit-
erature; identified additional cognitive needs in cases
where the evidence in the literature was insufficient or
inapplicable; for these they identified general and specific
objectives.
The experimental phase
For each objective identified an experimental study or spe-
cific intervention was planned and carried out according
to the study design or methods listed in table 1. The meth-
ods from already published studies are not described fur-
ther.
The study was submitted and approved by the Committee
for Ethics in Screening of the Regional Agency for Public
Health, 16th June 2002, approval n°1.
The endoscopy resources
We analysed the administrative database of hospital
records and the distribution of CCR admissions in the pre-
vious three years. According to the results of the analysis
we selected the endoscopy centres with the highest vol-
ume (more than 500 hospitalizations for CRC or adeno-
mas) and at least one centre in each province, to make
second level testing feasible in rural areas.
The CRCWG reviewed the literature regarding quality of
endoscopic services and defined quality indicators from a
disease management perspective, and addressed particu-
lar aspects of the relationship between health profession-
als and patient safety. The endoscopic centres selected
were evaluated based on these criteria.
To estimate the number of colonoscopies that would
result from extending CRCS to the whole region we con-
ducted a survey of the yearly census of the digestive endos-
copy centres by the Regina Elena Institute of Rome andBMC Public Health 2008, 8:318 http://www.biomedcentral.com/1471-2458/8/318
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the Italian Society of Digestive Endoscopy (SIED) [19].
We estimated the amount of additional work that would
result from screening, according to the following assump-
tions: a) the demand for colonoscopies produced by the
screening program to be entirely independent of current
demand for endoscopic exams, as they involve asympto-
matic subjects; b) the screening exams were to be per-
formed by facilities located in the subject's area of
Table 1: Main studies/interventions conducted and main results achieved during the experimental phase conducted by the Lazio 
Regional Public Health Authority.
Objectives Study/intervention 
conducted
Main results
To describe GPs' the knowledge, attitudes and 
recommendations about colorectal cancer 
screening.
Survey of the GPs [18] 24% of the GPs correctly recommended 
screening for CRC; 22% did not recommend 
any; 6% under-recommended and 47% over-
recommended. 22% of GPs recommended 
inappropriate follow up tests for patients with 
positive FOBT.
To describe attitudes and recommendations 
about colorectal cancer screening of the 
endoscopy centre physicians.
Survey of the endoscopy center's physicians 
[19]
Colonoscopy was perceived as the most 
effective screening test and was the most 
recommended (80%). FOBT was 
recommended by 61% of physicians and 
flexosigmoidoscopy by 11%. 50% over-
recommended screening.
To evaluate the effect of the provider (GPs 
versus hospital) on compliance FOBT 
screening.
Randomised controlled trial [20] 24.5% of 1192 GPs agreed to participate in the 
trial. The compliance with the GP was 54% vs 
17% with the hospital (RR 3.4; 95%IC 3.1–3.7). 
There was a high variability in the compliance 
obtained by the GPs. GPs with more than 25 
patient visits per day and those who incorrectly 
recommended screening had lower compliance 
(OR 0.74, IC95% 0.57–0.95 and OR 0.76, 
IC95% 0.59–0.97, respectively).
To assess the effect of the type of FOBT, 
Guaiac or immunochemical, on compliance.
Cluster-randomised trial [21]. The immunochemical test (OC-Hemodia, 
Eiken) had a compliance of 35.8% and the 
Guaiac of 30.4% (RR 1.20; CI95% 1.02–1.44). 
The Guaiac test had a higher prevalence of 
positives (10.3% vs 6.3%); and had higher 
variability in the results.
To identify determinants of non-compliance to 
FOBT screening.
Case-control study nested in the trial [22]. About 31% of non-compliant people reported 
never receiving the letter offering free 
screening; 17% of the sampled population had 
already been screened. The major reason for 
non-compliance was "lack of time" (30%), the 
major determinant of compliance was the 
distance from the test provider: OR > 30 
minutes vs < 15 minutes 0.3 (95%CI = 0.2–0.7).
To define criteria for a quality assurance 
program for CRC screening endoscopy.
A multidisciplinary panel consensus A system of quality indicators was created: 
protection of "users" rights; location in which 
endoscopy is performed; medical and non-
medical staff skills and training in colonoscopy 
and screening procedures; availability of CRCS-
specific management protocols; technical and 
professional processes; early outcomes 
evaluation; adverse effects and follow-up 
management.
To estimate increase in colonoscopies resulting 
from screening.
Analysis of administrative databases. Assuming a FOBT positivity rate of 3.5%, a 50% 
compliance rate, we estimated that nearly 50% 
more colonoscopies would be required.BMC Public Health 2008, 8:318 http://www.biomedcentral.com/1471-2458/8/318
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residence; c) a participation rate of 50% to the hypotheti-
cal campaign, and 3,5% of FOBT positivity.
The information system
To develop the organizational model we referred to RPHA
strategic choices (disease management approach, accord-
ing to a clinical governance framework [16,23]) and to
our original data.
According to the clinical governance framework, to assure
citizens/patients safety we also planned a clinical risk
management programme, using a systemic preventive
approach and applying the HFMEA protocol [24]. The
results have been incorporated into the organisational
model and the management software.
The feasibility study
A feasibility study on a target population of 300,000 has
been started according to the results of the decision-mak-
ing process. Here we present the results of the first two
years of activity, i.e. the first round. The following process
indicators are reported to summarise the results of the fea-
sibility study: the number of centres that started the pro-
gram; the proportion of GPs that agreed to participate in
the program; the proportion of the target population that
have been contacted (invited); the proportion of people
returning the test among the invited population; the pos-
itivity rate; the compliance to colonoscopy; the waiting
time for colonoscopy.
All 20 gastroenterology centres included in the pro-
gramme were visited by the RPHA before the program
began. The centres that actually started to screen were vis-
ited a second time to assess and evaluate the program's
progress and to identify critical points.
The screening strategies adopted were consistent with the
Ministry of Health guidelines on CRCS, consequently the
feasibility study did not need to be submitted to the Com-
mittee for Ethics.
Results
The evidence collection and production
According to the main evidence, the CRCWG adopted as
the screening strategy: FOB testing every two years for 50–
74 year olds and, for positives, colonoscopy. We chose
FOBT (OC-Hemodia, Eiken) based on the results of pop-
ulation trials [2], and the better compliance to FOBT than
flexible sigmoidoscopy in Lazio [25]. All the high-volume
endoscopy centres (more than 500 colonoscopies per
year), and at least one in each province, were involved to
face the predicted 50% increase in the colonoscopy bur-
den induced by screening.
The critical needs identified are listed in table 1; objectives
and study or intervention design are also shown. In order
to obtain the necessary information to organize the most
effective model of mass screening, according to CCRWG
indications, we studied the following topics: physicians'
attitudes and practices, type of FOBT, test provider, and
individual reasons for non-compliance [17].
The main results of the studies/interventions carried out
by the RPHA during the experimental phase are shown in
table 1; most have already been published [17-22].
The RPHA utilized all the information collected by the
above-mentioned studies to determine the best organiza-
tional model as summarized in table 2.
The organisational model (figure 1)
From the evidence found, we defined an organizational
model, an information system, and software.
The principal characteristics of the organizational model
are:
1. to use a disease management approach, including
patient treatment and follow-up, and managed according
to the principles of clinical governance.
2. the GP is the preferred provider because of its proximity
to the healthy population.
3. the GPs are not required to participate in the program,
but they receive an economic incentive if they participate:
about 10 € per person screened, based on an agreement
between the Regional Health Authority and the GPs' trade
unions.
4. to offer FOBT as the first-level test (immunochemical
method based on latex agglutination with automated ana-
lytical procedure). The patients of participating physicians
are invited to pick up the test at the GP's office; all patients
of non-participating doctors are directed by the local
health unit to pick up the test at the local gastroenterol-
ogy/endoscopy center; the letters were mailed by the
Regional Agency for Public Health using centre-specific
templates (timetable, addresses and letterhead), but the
timing was determined by the gastroenterology centre
according to their availability for providing tests and
colonoscopies; A reminder was sent to non-responders
after three months. The GPs decided when and how
(phone, letter or other) to contact their target popula-
tions.
5. the result of the test was automatically sent by mail if
negative; if positive, the result should have been commu-BMC Public Health 2008, 8:318 http://www.biomedcentral.com/1471-2458/8/318
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nicated by phone and letter, in the same phone contact a
date for colonoscopy should have been fixed.
6. the gastroenterology centres (20 in the region) collect
all the faecal samples and perform the immunochemical
analysis and plan the colonoscopy for all the positive sam-
ples (and possibly immediate polipectomy).
7. the target population refers to the closest gastroenterol-
ogy centre, independent of administrative borders
Table 2: Use of data gathered to define the organizational model.
Question Experimental evidence/elements from Organizational choices
Which Organizational framework? ▪ Literature on organisation topics
▪ RPHA Mission
Disease management as a factor to achieve 
effectiveness
Which Screening test? ▪ Literature evidence
▪ European Commission Recommendation [4]
▪ FOBT has a compliance of 3.1 compared to 
FS [25]
FOBT as screening test
Which FOBT type? ▪ Literature evidence
▪ The immunochemical test had a 20% higher 
compliance than Guaiac.
▪ Higher variability in the results obtained with 
the Guaiac test than the immunochemical [21].
Immunochemical test as FOBT test
Which FOBT provider? ▪ The compliance to the FOBT with GPs was 
3.4 times higher than compliance with the 
hospital, independent of the type of test and 
geographical area [20]
General Practitioners as main provider
What the GPs think about screening? What 
they can do?
▪ GPs currently do not correctly follow up a 
positive FOBT [18].
▪ There was high variability among GPs: GPs 
with a heavy work load and those who 
incorrectly recommended FOBT for CRCS 
obtained lower compliance [20]
the GPs are not required to participate in the 
program, but they receive an economic 
incentive if they do.
Reference diagnostic Centre ▪ Number of CRC cases treated by hospital in 
the previous 3 yrs plus a guarantee of 
accessibility in rural areas
▪ A shared system of quality indicators and 
standards
▪ Attending a re-training course
▪ Centres belonging to Hospitals that have > 
500 patients
▪ Centres complying with quality indicators
Why people do not respond to screening 
invitation?
▪ The first reported reason for non-compliance 
was "lack of time" (30%).
▪ The major determinant of compliance was the 
distance from the test provider. [22]
Territorial zoning regardless of administrative 
borders
Who manage the follow up of positives? ▪ GPs undependable for correct follow-up [18]
▪ Gastroenterologists not skilled in managing 
mass screening criteria [19]
▪ Neither physicians at endoscopy centers nor 
GPs tend to follow screening guidelines.
▪ Centralized management
▪ Guidelines-based software
Which software for screening management? ▪ Previous breast cancer screening experience 
about non-efficiency of in-house softwares, 
different for each Local Health Unit
▪ Mission: disease-management oriented
▪ Web based software
For each question, the experimental evidence or the elements influencing the final choice are reportedBMC Public Health 2008, 8:318 http://www.biomedcentral.com/1471-2458/8/318
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8. the Local Health Unit must establish the administrative
framework, and serve as the program's liaison with the
GPs and the gastroenterology centres.
The Information System
A fundamental part of the organisational model is the
information system. It is directly managed by the RPHA.
The IS is structured in three sections: because there is no
cancer registry in our region, the information about inci-
dence and mortality is taken from the integration of the
mortality database, the hospital discharge registry; the
information about the screening process and outcomes is
reported by the on-line record of each screening episode;
an adverse events and near-misses information system has
been planned.
A fundamental part of the information system as a tool in
disease management is the software. We developed a web-
based application with the following characteristics:
instant access to information by any user, no need for sys-
tem updates, few hardware needs by the user, information
centralized in a single database, possibility of external
housing for the server platform, integration with other
technological tools (i.e. immuno-test analysers) and with
databases (hospital discharge records, out-patient records,
mortality database); automatic quality controls to assure
The dotted lines represents the information flow, the solid lines represents the material flows Figure 1
The dotted lines represents the information flow, the solid lines represents the material flows. The test tubes 
represents the faecal samples transported from the GPs' clinics to the gastroenterology centre; the men represent the target 
population going to the test provider to pick up and return the samples; the letter envelopes represent the invitation by the 
program to the target population. In the region there are 12 Local Health Units and 20 gastroenterology centres, the target 
population of each GP and gastroenterology centre is not necessarily restricted to the LHU borders.
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that the health professionals involved comply with proto-
cols.
Results of the feasibility study
The results of the feasibility study are summarised in table
3. The results of the feasibility study can be summarised as
follows (table 3, last column): half of the centres started
the program, only one invited the entire target population
in the two-year round, GP participation was low but var-
ied greatly; the compliance to FOBT with the gastroenter-
ology centre was 16.6%. On the other hand, compliance
rates observed for the GPs were not comparable, since we
could not determine the denominator of the ratio (i.e. the
invited population); in fact most of the GPs suggested the
test to patients who came to their office for other reasons,
and did not contact the entire target population.
Out of the 7196 samples returned, 288 could not be inter-
preted because the personal data or the sample itself was
lost. Compliance to colonoscopy was very low, but during
the site visits we observed that some colonoscopies had
been performed without being registered; unfortunately it
was impossible to quantify the phenomenon. Generally
analyses of second level testing was limited due to the
amount of missing information.
Carcinoma detection rates were 2.2/1000 and 2.4/1000
respectively for women and men, while the detection rates
for high-grade adenomas were 11/1000 and 7.5/1000.
Waiting times for colonoscopy varied greatly but tended
to be long, with more than 22% waiting more than 2
months for colonoscopy.
The principal critical points noted during the site visits
were: gastroenterology centre administrative staff related
poorly to the healthy population, they had little experi-
ence managing the high number of patients and tests.
Some of the centres were not easily accessible, i.e. hard to
find, and required very short time for test pick up and
return. There was such little time set aside for screening
colonoscopies that the second diagnostic level was a bot-
tleneck for the screening program, slowing down the
rhythm of the entire screening process. Internet access at
some of the centres was inadequate and unreliable, which
prevented using the software.
Discussion
Choosing an organisational model: the grey areas
We thoroughly planned all stages of the screening process,
taking into account its various aspects in the effort to
establish the best baseline conditions for CRCS for our
target population. To identify the best options we adopted
the principles of evidence-based medicine, applying strat-
egies that had preferably been tested in trials or, if trials
were not available or not feasible, had solutions recom-
mended by sound observational studies. We decided also
to produce our own evidence if we noted contextual dif-
ferences that hampered the generalizability of other stud-
ies' results (GP's effect on compliance and GPs' attitudes)
[20] or if there was not enough literature on the topic
(effect of the type of test on compliance, gastroenterolo-
gists' attitudes) [21]. Nevertheless, grey areas remain and
some of the solutions were adopted arbitrarily.
The colonoscopy workload was identified as a critical
point, consequently we needed almost all gastroenterol-
ogy centres with medium-high volume of activity in our
region to participate in the program independently of
their administrative condition, in particular we were inter-
ested in involving university hospitals and clinical
research hospitals, institutions usually not involved in
breast or cervical cancer screening. With this aim we made
three decisions: 1) we decided to put the FOBT reading
machine (OC sensor) in the gastroenterology centre; con-
sequently the system used 20 machines to interpret the
test, an inefficient solution that increased the cost per test;
furthermore gastroenterology centres do not have experi-
ence managing routine diagnostic tests and or handling a
very high number of negative responses. 2) We decided to
use the nearest gastroenterology centre as the test provider
for the target population from non-participating GPs;
other public clinics could be used to bring the test pro-
vider closer to the healthy target population. 3) As a con-
sequence of the central roles played by the GP and the
gastroenterology centres, the Local Health Unit had a mar-
ginal role in the screening program management.
Finally the economic incentive offered to the GPs was
established with an agreement between the Regional
Health Authority ant the GPs' trade unions, but we do not
know if other forms of voluntary participation would be
less effective.
What did not work
First problem: only half of the centres chose to participate.
One of the possible barriers that we identified is that the
responsibility associated with prevention is unclear: in
our health system the Local Health Unit is accountable for
the health of the resident population within its borders,
but most of the gastroenterology centres depends on the
administrations of independent hospitals. In our model
we tried to make the gastroenterology centre accountable
for a preventive intervention and the LHU a sort of third
player. This often resulted in a sort shifting of blame
between the gastroenterology centres and the LHU.
Second problem: very few GPs agreed to participate, but
wide variability was observed. It was clear that some LHUs
did not have the administrative skills to enrol the GPs in
the project, but all the coordinators working in the LHUBMC Public Health 2008, 8:318 http://www.biomedcentral.com/1471-2458/8/318
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Table 3: Results of the feasibility study: process indicators and critical points
Indicators values range among 
centres
critical points
Program activation
target population 300000
N of centres started 50% (10/20) See discussion
population of active centres 65922 (22,0%)
the following data refer only to the active centres
GPs participation
% of GP that agreed to participate 10,8% (57/526) 60,0% (57/95)$ (0,0 – 90,0) GPs were actually involved in only 6 centres: in some 
LHUs,  
administrative barriers prevented the participation; no 
interest by the GPs;
some GPs initially agreed but never send the list of 
target population.
Program extension (invited population/target)
Total 41,1% (65922) Most of the GPs do not actively invite, but only 
distribute the tests  
opportunistically: difficult to exactly determine the 
contacted
population.
GP 21,0% (20315) (42,2–8,0)
Hospital 50,1% (45607) (100,0–14,4) Too slow invitation rhythm: the program did not cover 
the 
whole target population within the two-year period.
Compliance to FOBT (proportion of returned test/invited population)
all 26,5% (27124)
GP 79,9% (4258) (73,1 – 91,8) Impossible to monitor what the GP does. The 
compliance is biased  
because of opportunistic strategies, without active 
invitation 
by the GP.
Hospital 16,6% (22866) (4,7 – 34,1) Low compliance: no accessibility
Positivity rate
7,1% (6908) (3,2 – 9,2) For 288 (%) tests the results were not available: high 
level of 
lost samples and lost responses.
Compliance to colonoscopy°
49,1% (288) (0,0 – 76,7) Impossible to determine if missing data or low 
compliance.
Detection rate*
Total 17,1/1000 (N 71) Very few centres input data correctly and timely.
cancer 3,6/1000 (N 15)
high grade adenomas 13,5/1000 (N 56)
Low grade adenomas N 17
Waiting time for colonoscopy§
within 30 days from FOBT 55,1% Few colonoscopies due, but centres too busy. Very few 
centres input data correctly and timely.
31 and 60 days from FOBT 22,8%
after 60 days from FOBT 22,1%
° Based on 288 positive tests with complete follow up; high grade adenomas includes: 8% tubular with high grade dysplasia; 25% tubular-villous with 
high grade dysplasia; 24% tubular-villous with moderate dysplasia; 24% tubular-villous with low grade dysplasia; 4% villous with high grade dysplasia; 
3% villous with moderate dysplasia; 1% villous with low grade dysplasia; 4% hyperplasic polyps; 5% 3 or more adenomas with low moderate 
dysplasia; 3% unknown. Low grade adenomas include: 73% of low grade and 23% of moderate tubular dysplasia; 4% unknown.
* Based on 4155 tests with full information.
§ Based on 140 colonoscopies with full information
$ Considering only the 6 centres that activated the collaboration with the GPsBMC Public Health 2008, 8:318 http://www.biomedcentral.com/1471-2458/8/318
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screening programs (usually involved also in the organisa-
tion of breast and cervical cancer screening) reported that
this task was difficult and time consuming.
We had great difficulty in determining how many people
in the target population had been invited by the GP. This
was the consequence of the freedoms obtained by the
GPs' trade unions in the agreement: in fact, during the
trial the target population that had their GP as test pro-
vider received a letter with a time schedule to pick up and
return the FOBT; in the feasibility study we could not send
mail to patients of the participating GPs because of union
opposition. At the end of the round we were not sure if the
GP's entire target population had had equal opportunity
to be tested, generating an equality issue. The role of GPs
in increasing screening attendance has been observed in
several studies [26-30], but we faced so many difficulties
that the advantages were largely outweighed by the prob-
lems; this is probably why other authors suggested the
GPs' role be kept at signing the invitation letter [29,30].
Some LHUs had problems in respecting the 7 day time
period to transport the faecal samples from the GPs' clin-
ics to the gastroenterology centre.
The compliance in some gastroenterology centres was
unacceptably low, confirming the results of the experi-
mental phase [20,21]. Even though it was confirmed in
the two settings of the experimental and pilot phases, the
compliance rate obtained in our region by the gastroenter-
ology centres is much lower than the Italian average
(46%) [31]. These centres are used to treating a small
number of ill patients and giving them a lot of attention,
but they are not used to managing hundreds of people.
Consequently they substantially reduced their availability
to patients returning the FOBT.
The rhythm of mailing invitations to the target population
had to be slowed in almost all centres because the colon-
oscopy workload was too high. This problem also
occurred at centres that performed very few colonoscop-
ies, revealing that they were not at all committed to
screening and reserved very little time for this task. As a
result, only one of the 20 centres invited the entire target
population in the two year period.
Finally, there were also some problems with the manage-
ment software. Some GPs did not enter all the required
information, leading to the very confusing and unaccept-
able situation of sample results not being ascribed to a
patient. Some gastroenterology centres had significant
problems in entering colonoscopy results, mostly due to
poor web connections, consequently the detection rates
and colonoscopy compliance figures are not reliable. Nev-
ertheless, the detection rate is in line with results of other
Italian screening programs, while the compliance to
colonoscopy is lower (41% vs 82%) [31].
Conclusion (Lessons from failures)
By analysing all the problems we encountered, a single
underlying cause is apparent: a lack of accountability. In
our opinion, the program will work when responsibilities
are clearly re-established, the most important and difficult
being the institution's and staff's level of commitment to
and involvement with the program. This is not the first
experiment that has failed because of the difficulty in
accountability of health services and their employees. The
problem is more evident in the implementation of pre-
ventive interventions: in a CRCS program physicians do
not have to face a health problem posed by the patient,
but must themselves motivate prevention in the healthy.
We took a disease management approach [5] to ensure
effectiveness, taking into account the role that the organi-
sation of the health care system plays in determining qual-
ity and effectiveness [32,33]. Although the literature
supports a disease-management approach, it does have
some limitations. More general research is needed to
assess effectiveness and the relative cost-effectiveness of
different implementation strategies [34,35]; more agree-
ment is also necessary on definitions and methodology
[36].
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